No price history available.
Key financial summary
Financials in HKD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | HKDm | 2,190 | 2,955 | 2,830 | 3,172 | 3,364 | 3,737 | N/A | N/A |
| Operating profit | HKDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | HKDm | 108 | 361 | 220 | 404 | 408 | 597 | N/A | N/A |
| EPS reported | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | HKDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | HKDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | HKDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | HKD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in HKD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Modern Dental Group Limited, an investment holding entity, is a prominent provider specializing in the manufacturing and worldwide distribution of dental prosthetic devices. Its extensive operations reach various international markets, including Europe, Greater China, North America, and Australia. The company's offerings are structured across three primary segments. The Fixed Prosthetic Devices division provides restorative dental solutions such as crowns, bridges, and implants. Concurrently, the Removable Prosthetic Devices segment is dedicated to producing both full and partial dentures, which can include metal frameworks or be entirely metal-free. Furthermore, its "Others" segment encompasses a diverse range of products like orthodontic appliances, sports guards, anti-snoring devices, raw materials, and various dental equipment. This segment also extends to offering professional services, including educational events and seminars. Modern Dental Group serves a broad clientele comprising dentists, dental clinics, hospitals, distributors, and other professional customers. Its comprehensive product line is marketed under numerous recognized brands, such as Permadental & Semperdent, Schmidt, Apex Digital Dental, Elysee, Labocast, Modern Dental Laboratory, Yangzhijing, Southern Cross Dental, Andent, Modern Dental USA, Sundance Dental, Quantum Dental, TrioClear, and Digitek Dental. The company was established in 1986 and is headquartered in Kowloon, Hong Kong.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Modern Dental Group Limited (3600.HK)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Modern Dental Group Limited, an investment holding entity, is a prominent provider specializing in the manufacturing and worldwide distribution of dental prosthetic devices. Its extensive operations reach various international markets, including Europe, Greater China, North America, and Australia. The company's offerings are structured across three primary segments. The Fixed Prosthetic Devices division provides restorative dental solutions such as crowns, bridges, and implants. Concurrently, the Removable Prosthetic Devices segment is dedicated to producing both full and partial dentures, which can include metal frameworks or be entirely metal-free. Furthermore, its "Others" segment encompasses a diverse range of products like orthodontic appliances, sports guards, anti-snoring devices, raw materials, and various dental equipment. This segment also extends to offering professional services, including educational events and seminars. Modern Dental Group serves a broad clientele comprising dentists, dental clinics, hospitals, distributors, and other professional customers. Its comprehensive product line is marketed under numerous recognized brands, such as Permadental & Semperdent, Schmidt, Apex Digital Dental, Elysee, Labocast, Modern Dental Laboratory, Yangzhijing, Southern Cross Dental, Andent, Modern Dental USA, Sundance Dental, Quantum Dental, TrioClear, and Digitek Dental. The company was established in 1986 and is headquartered in Kowloon, Hong Kong.